About SESAP 18 Advanced CME

All continuing medical Education (CME) credit for SESAP^® 18 Advanced must be claimed by October 16, 2025. SESAP 18 Advanced will be available online until December 31, 2025, when the edition will be retired.

SESAP^® 18 Advanced is intended for surgeons seeking in-depth knowledge in selected areas. Upon completion of SESAP 18 Advanced, participants should be able to:

• Assess their initial knowledge of surgical content in selected topics that may be complex, ambiguous, and evolving,
• Exhibit mastery of advanced surgical content to achieve required criteria in each module,
• Exemplify lifelong excellence in surgery,
• Improve their surgical practice through the application of evidence-based knowledge,
• Stay current with emerging and complex surgical advances.

To earn continuing medical education (CME) credit, participants must use the SESAP 18 Advanced CME modules. SESAP 18 Advanced includes 332 questions across 7 modules, all of which must be completed to earn the maximum of 112 CME credits. Credit is earned and claimed by module. Individuals who subscribe by module can earn CME credit only for those modules selected. Credits assigned to each module are as follows:

Participants enrolled for CME credit will be asked to read each question, select an answer, and review the corresponding critique and preferred answer. Participants will test their mastery of the content just learned by answering the same questions in a scrambled fashion and must achieve a score of 80%. If the score is less than 80%, the participant will be asked to review only the incorrect questions and answer those questions again until a score of 80% is achieved. If a cumulative score of 80% correct is not achieved after the third attempt, the participant will be asked to start the entire section over again.

Each module contains two parts. Each part must be completed with a score of 80 percent to claim credit for the entire module. After achieving a score of 80 percent for each module, participants will be asked to complete an online evaluation form and submit data to the American College of Surgeons (ACS) using the internet. Upon successful submission, a CME certificate will be available to print. SESAP 18 Advanced is certified for credit through October 16, 2025.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program.

Transmitting CME Credit to the American Board of Surgery

To ensure your SESAP 18 Advanced CME data are transmitted appropriately from the American College of Surgeons (ACS) to the American Board of Surgery (ABS), please use the ACS MyCME Portal. You will need your ACS ID log-in. This will be your membership number or the ACS ID you received when you created your ACS account. If you need assistance with the ACS ID contact Log-in Help.

Step-by-Step Instructions to Access MyCME and Transmit Your CME Data

1. Log into MyCME.
2. Once logged in, you will see your name at the top right of the page.
3. Select the “Send CME Data” tab.
4. Select the “Specialty Board” option.
5. From the recipient dropdown menu, select American Board of Surgery.
6. Select “I Agree.”
7. Enter your ABS ID.
8. Enter your month and day of birth.
9. Confirm that your email address is correct.
10. Enter the desired start and end dates for your CME data range and click “Get Select Dates.”
11. Review the transcript data to confirm it is correct.
12. Once satisfied with the “Send to ABS” criteria, click the “Yes” button.

After your CME credits are sent, you will see a confirmation page. After 24 hours, you can log into your ABS account to confirm the credits are in your ABS CME Repository.

For questions about the MyCME portal, contact mycme@facs.org. For questions regarding the ABS requirements, please contact ABS at cc@absurgery.org.

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any ineligible company held in the last 24 months.

• Ineligible Company: The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
• Financial Relationships: Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
• Conflict of Interest: Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

Planning Committee

Lorrie A. Langdale, MD, FACS, MAMSE, SESAP 18 Advanced Program Director (Nothing to disclose)

John A. Weigelt, MD, DVM, FACS, MAMSE, SESAP 18 Program Director (Nothing to disclose)

David C. Borgstrom, MD, MBA, FACS (Nothing to disclose)

Judy Boughey, MBBCh, FACS (Principal Investigator—Lilly)

Karen Brasel, MD, MPH, FACS, MAMSE (Nothing to disclose)

David A. Bull, MD, FACS (Nothing to disclose)

Dan Eisenberg, MD, MS, FACS, FASMBS (Nothing to disclose)

Jason B. Fleming, MD, FACS (Advisor—Glycosbio Food Services, Inc.; Advisor—Bio-Path Holdings, Inc.; Advisor—Natera; Advisor—Panther Therapeutics, Inc.)

Charles M. Friel, MD, FACS, FASCRS (Nothing to disclose)

Sean J. Langenfeld, MD, FACS, FASCRS (Nothing to disclose)

David J. Milia, MD, FACS (Nothing to disclose)

Lena M. Napolitano, MD, FACS, FCCP, MCCM, MAMSE (Nothing to disclose)

John T. Paige, MD, FACS (Co-editor— Oxford University Press; Co-editor—Springer Nature; Principal Investigator—SGEA/IAMSE; Site Investigator—Acell Inc.)

Walter E. Pofahl II, MD, FACS (Nothing to disclose)

John T. Vetto, MD, FACS (Speaker—Castle Biosciences; Spouse employer—Gilead Bioscience)

Tracy S. Wang, MD, MPH, FACS, FSSO (Nothing to disclose)

Travis P. Webb, MD, MHPE, FACS, MAMSE (Nothing to disclose)

Catherine M. Wittgen, MD, FACS (Consultant—Bristol Meyers Squibb, Pfizer, Organogenesis, CVRx)

Authors

Tania Arora, MD, FACS (Nothing to disclose)

Judy Boughey, MBBCh, FACS (Principal Investigator—Lilly)

Tawnya L. Bowles, MD, FACS (Nothing to disclose)

Karen Brasel, MD, MPH, FACS, MAMSE (Nothing to disclose)

David A. Bull, MD, FACS (Nothing to disclose)

Casey M. Calkins, MD, FACS (Nothing to disclose)

Thomas Carver, MD, FACS (Principal investigator—Innovital, Inc.)

Jeffrey Chipman, MD, FACS (Nothing to disclose)

Kathryn Coan, MD, FACS (Nothing to disclose)

Sean Dineen, MD, FACS (Nothing to disclose)

Anne Ehlers, MD, MPH, FACS (Nothing to disclose)

Dan Eisenberg, MD, MS, FACS, FASMBS (Nothing to disclose)

Dina M. Elaraj, MD, FACS (Nothing to disclose)

Mary E. Fallat, MD, FACS (Nothing to disclose)

Charles M. Friel, MD, FACS, FASCRS (Nothing to disclose)

David A. Gerber, MD, FACS (Consultant—Medtronic, Inc.; Stock options—BiomedInnovations, LLC)

Sara Javid, MD, FACS (Nothing to disclose)

Kyle Kalkwarf, MD, FACS (Nothing to disclose)

Andrew Kastenmeier, MD, FACS (Speaker—Gore)

Lorrie A. Langdale, MD, FACS, MAMSE (Nothing to disclose)

Sean J. Langenfeld, MD, FACS, FASCRS (Nothing to disclose)

Linda L. Maerz, MD, FACS, FCCM (Nothing to disclose)

Samuel Mandell, MD, MPH, FACS (Author—UpToDate)

David E. Meyer, MD, MS, FACS (Nothing to disclose)

John T. Miura, MD, FACS (Nothing to disclose)

Lena M. Napolitano, MD, FACS, FCCP, MCCM, MAMSE (Nothing to disclose)

Leigh A. Neumayer, MD, MS, MBA, FACS, MAMSE (Nothing to disclose)

John T. Paige, MD, FACS, MAMSE (Co-editor— Oxford University Press, Springer Nature; Principal Investigator—SGEA/IAMSE; Site Investigator—Acell Inc.)

Jennifer E. Rosen, MD, FACS (Nothing to disclose)

Jonathan G. Sham, MD, MBEE, FACS (Speaker—Boston Scientific)

Brian P. Smith, MD, FACS (Nothing to disclose)

Deborah M. Stein, MD, MPH, FACS (Nothing to disclose)

Insoo Suh, MD, FACS (Consultant—Prescient Surgical, Medtronic, GLG; Scientific Advisory Board Member—Iota Biosciences; Expert witness—RPWG)

Jennifer Tseng, MD, FACS (Consultant—Castle Biosciences)

John T. Vetto, MD, FACS (Speaker—Castle Biosciences; Spouse employer—Gilead Bioscience)

Tracy S. Wang, MD, MPH, FACS, FSSO (Nothing to disclose)

Travis P. Webb, MD, MHPE, FACS, MAMSE (Nothing to disclose)

Catherine M. Wittgen, MD, FACS (Consultant—Bristol Meyers Squibb, Pfizer, Organogenesis, CVRx)

Andrew S. Wright, MD, FACS (Nothing to disclose)

Nicole Zern, MD, FACS (Nothing to disclose)

Consultants

Ajit K. Sachdeva, MD, FACS, FRCSC, FSACME, MAMSE (Nothing to disclose)

Patrice Gabler Blair, DrPH, MPH (Nothing to disclose)

Staff

Julia C. Dudek, MPH (Nothing to disclose)

Chrysa M. Cullather, MS (Nothing to disclose)

Katherine M. Greenock, MS (Nothing to disclose)

Education Credits of Excellence

Surgeons interested in achieving higher levels of cognitive skills have the opportunity to earn Education Credits of Excellence offered by the ACS Division of Education and approved by the ACS Board of Regents. For each category, participants have an option for additional study to demonstrate a higher level of expertise in the content area. The Education Credits of Excellence are entirely optional and are designed to encourage further learning and challenge surgeons who want to pursue a higher level of achievement.

Royal College of Physicians and Surgeons of Canada Accreditation

Through an agreement between the American College of Surgeons and the Royal College of Physicians and Surgeons of Canada, MOC Program participants may record completed self-assessment programs or simulation activities developed and accredited by the American College of Surgeons in Section 3 of the Royal College’s MOC Program.